CAR-T Cell Therapy – Frederick Locke, MD, and Robert Figlin, MD, discuss clinical highlights from ASH 2018

CAR-T Cell Therapy – Frederick Locke, MD, and Robert Figlin, MD, discuss clinical highlights from ASH 2018

Wednesday December 19, 2018

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Frederick Locke, MD, Program Co-Leader, Immunology, Moffitt Cancer Center discuss CAR-T clinical highlights from ASH 2018

Featured Videos

Paul G. Richardson, MD, regarding the updated FORTE trial data in multiple myeloma

Paul G. Richardson, MD, considers progression-free survival in MM when treating with isatuximab

Sandip Patel, MD, comments on the top stories in lung cancer from ASCO 2019